Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
ALTERITY THERAPEUTICS LTD (PRAN)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
10/02/2023
F-3
Form F-3 - Registration statement by foreign private issuers:
08/23/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
Alterity Granted New Composition of Matter Patent in Europe
"
08/22/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
ATH to present New Biomarker data at International Congress
"
08/15/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
Alterity receives a $4.74 million R&D Tax Refund
"
07/31/2023
6-K
Quarterly results
07/26/2023
6-K
Quarterly results
04/27/2023
6-K
Quarterly results
04/26/2023
6-K
Quarterly results
04/04/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
First Patient Enrolled in UK in Phase II Clinical Trial
"
03/16/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
Application for quotation of securities - ATH
"
03/16/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
Notice Under Section 708A
"
03/15/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
Proposed issue of securities - ATH
"
03/14/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
US patent grant and license agreement
"
03/09/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
Investor Webinar Presentation
"
02/28/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
Half Yearly Report and Accounts
"
02/02/2023
6-K
Quarterly results
01/31/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
Appendix 4C and Quarterly Cash Flow Report
"
01/30/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
ATH434 Prevents Brain Cell loss in Parkinsons Animal Model
"
01/25/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
ATH434 Clinical Trial Launched in Italy
"
01/09/2023
6-K
Quarterly results
01/06/2023
6-K
Quarterly results
01/03/2023
6-K
Quarterly results
12/29/2022
6-K
Quarterly results
12/15/2022
6-K
Quarterly results
12/15/2022
6-K
Quarterly results
11/16/2022
6-K
Quarterly results
11/14/2022
6-K
Quarterly results
11/14/2022
6-K
Quarterly results
11/14/2022
6-K
Quarterly results
11/07/2022
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
Presentation of bioMUSE urinary symptom profile data
"
10/31/2022
SC 13D/A
Life Biosciences LLC reports a 4.7% stake in Alterity Therapeutics Limited
10/28/2022
6-K
Quarterly results
10/26/2022
6-K
Quarterly results
10/13/2022
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
REPORT OF FOREIGN PRIVATE ISSUER
",
"
ATH434 Clinical Trial launched in Australia
"
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy